New oral pill for COVID-19 home treatment

The continued emergence of novel and potentially threatened SARS-CoV-2 variants, the latest of which is the highly pathogenic Omicron variant (VOC), is evidence that the coronavirus 2019 (COVID-19) pandemic is far from over, although The massive spread of vaccines. As cases and hospitalizations continue to rise in many countries, new treatments are being sought to … Read more

New drug targeting LF and onchocerciasis begins its first in human trial in Liverpool

A new drug developed by a partnership led by LSTM, which targets neglected tropical diseases, lymphatic filariasis and onchocerciasis, has begun its first human trial. Lymphatic filariasis and onchocerciasis are debilitating diseases that affect more than 150 million people worldwide. Both are caused by parasitic worms, and this specific drug AWZ1066S was designed to targetWolbachia, … Read more